In conclusion, HD-MA and HD-HPC have established a role as, second-line endocrine therapy or salvage measurement for the postmenopausal women with advanced, relapsed and refractory breast cancer.
作者认为，HD—MA和HD—HPC作为第二线内分泌治疗手段，对于晚期、复发或难治性乳腺癌是安全、有效并有其独具的优点的。
In conclusion, HD-MA and HD-HPC have established a role as, second-line endocrine therapy or salvage measurement for the postmenopausal women with advanced, relapsed and refractory breast cancer.
作者认为，HD—MA和HD—HPC作为第二线内分泌治疗手段，对于晚期、复发或难治性乳腺癌是安全、有效并有其独具的优点的。
应用推荐